Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
Conditions:   Uveal Melanoma;   Ocular Melanoma Interventions:   Drug: Pembrolizumab;   Drug: Olaparib Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2022 Category: Research Source Type: clinical trials

Adjuvant Melatonin for Uveal Melanoma
Conditions:   Uveal Melanoma;   Uveal Melanoma, Posterior, Medium/Large Size;   Eye Cancer, Intraocular Melanoma Intervention:   Drug: Melatonin Sponsors:   Gustav Stalhammar;   Karolinska Trial Alliance;   Swedish Cancer Society;   The Swedish Eye Foundation (Ögonfonden);   The Swedish Society of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2022 Category: Research Source Type: clinical trials